Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China flag China · Delayed Price · Currency is CNY
8.81
-0.15 (-1.67%)
May 12, 2026, 3:00 PM CST

SHA:688098 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-23.68-24.97-44.7431.5261.1110.2
Depreciation & Amortization
75.4375.4368.3663.4557.0743.74
Other Amortization
--0.28---
Loss (Gain) From Sale of Assets
-0.26-0.26-0.04-0-0.140.6
Asset Writedown & Restructuring Costs
-2.37-2.3728.460.40.24-
Loss (Gain) From Sale of Investments
33-2.67-5.79-3.31-12.08
Provision & Write-off of Bad Debts
--8.453.128.51.65
Other Operating Activities
1.113.9-3.93-1.68-0.11-5.82
Change in Accounts Receivable
-34.22-34.225.03-52.18-78.96-27.68
Change in Inventory
0.640.6416.683.58-11.9-32.27
Change in Accounts Payable
3.293.2921.42-33.15-17.885.25
Change in Other Net Operating Assets
----6.81-6.145.07
Operating Cash Flow
21.5633.0889.363.539.0990.12
Operating Cash Flow Growth
-74.69%-62.99%2434.71%-61.21%-89.92%-19.34%
Capital Expenditures
-41.96-45.23-84.91-129.63-93.12-188.16
Sale of Property, Plant & Equipment
0.520.52--0.860.5
Investment in Securities
-26.46-878.94141.45119.349.4
Other Investing Activities
3.413.552.2910.058.9811.06
Investing Cash Flow
-64.5-49.16-3.6821.8636.01-127.21
Long-Term Debt Issued
--14---
Total Debt Issued
--14---
Long-Term Debt Repaid
--1.12-0.78-0.37-0.12-0.14
Net Debt Issued (Repaid)
-1.12-1.1213.22-0.37-0.12-0.14
Issuance of Common Stock
-----8.14
Common Dividends Paid
-0.26-0.27-14.35-32.77-36.81-40.81
Other Financing Activities
-0.37-2.12-18.230.050.240.51
Financing Cash Flow
-1.75-3.51-19.36-33.09-36.7-32.3
Foreign Exchange Rate Adjustments
-0-0000-0
Net Cash Flow
-44.69-19.5966.33-7.718.4-69.39
Free Cash Flow
-20.4-12.164.45-126.11-84.04-98.04
Free Cash Flow Margin
-7.50%-4.22%1.47%-41.83%-25.57%-27.35%
Free Cash Flow Per Share
--0.030.01-0.32-0.21-0.24
Cash Income Tax Paid
13.412.2315.0630.9324.2528.43
Levered Free Cash Flow
12.7619.3818.35-113.08-92.62-126.34
Unlevered Free Cash Flow
1319.3818.36-113.08-92.62-126.34
Change in Working Capital
-31.66-31.6635.19-87.5-114.26-48.17
Source: S&P Global Market Intelligence. Standard template. Financial Sources.